tions were noted in 2 patients and hardware problems (electrode dislocation and breakage of the extension cable) in 1 patient. Conclusion: Our data showed Gpi-DBS to offer a very effective and safe therapy for different kinds of primary dystonia, with a significant long-term benefit in the majority of cases.
Introduction
In most cases, primary dystonia with its different phenotypes is a severely disabling disease. Etiologically, a pathological process within the basal ganglia is supposed to be responsible for decreased motor cortex inhibition. Affected patients suffer from repetitive twisting movements or abnormal postures due to involuntary muscle contractions [1, 2] . While conservative (medical) treatment options are extremely limited for generalized dystonia, in segmental dystonia, injections of botulinum toxin can alleviate symptoms for extended periods, but can also fail after repeated application [3, 4] .
For many years, stereotactic operations have been an alternative for patients with medically intractable dystonia. In the past, surgical treatment consisted mainly of stereotactically guided localized tissue destruction (e.g. thermocoagulation) inside thalamic motor nuclei or inside the globus pallidus internus (GPi). Although the motor symptoms improved following lesioning, there is also a considerable risk of adverse events and, moreover, the initial improvement can decrease over time [5] [6] [7] . In contrast to ablative stereotactic surgery, chronic stimulation can be safely used bilaterally. In addition, most stimulation-induced side effects and/or a decrease in the clinical benefit can be corrected by readjustment of stimulation parameters. During the last years, several study groups presented data on rather small patient cohorts using the GPi as target for deep brain stimulation (DBS) [8] [9] [10] [11] . Only six recently published reports of larger series covered 1 15 patients [12] [13] [14] [15] [16] [17] . Based on convincing solid data from the prospective controlled studies by Vidailhet et al. [16, 17] along with the results of the prospective randomized controlled two-arm study by Kupsch et al. [18] , which showed the efficacy of bilateral GPi stimulation in comparison to sham stimulation in 40 patients with primary dystonia, evidence of the effectiveness of GPi-DBS in dystonia was accumulating. However, the mean follow-up of the cited studies was 22.3 months. Therefore, apart from the 3-year results from the controlled prospective series by Vidailhet et al. [17] or the very recently published data from a small case series (only 7 patients with primary dystonia) by Loher [19] , little is known about the longterm efficacy and safety of chronic GPi stimulation in different types of dystonia or about pretreatment factors possibly predicting clinical outcome. To be able to address these problems in the present analysis, we pooled the immediate postoperative results and long-term follow-up data from two stereotactic centers analyzing 18 patients suffering from different types of primary dystonia with special focus on long-term efficacy and safety.
Patients and Methods

Patient Population/Inclusion Criteria
Patients with a history of severely disabling, medically intractable primary dystonia and a follow-up of 6 36 months after implantation of GPi electrodes were considered eligible for the present analysis. Finally, a cohort of 18 (Munich: 12, Cologne: 6) consecutive patients (12 females, 6 males; mean age: 42.3 years, range 12-78 years) suffering from primary generalized (9), segmental (6) and focal (3) dystonia treated with GPi-DBS between February 1999 and February 2002 were included. The reference point of this study was the date of implantation. All patients who suffered from cervical dystonia had initially been successfully treated with botulinum toxin. DBS was offered when the positive effect of the injections weakened, most probably due to an immune response against this substance. Patients with generalized dystonia were screened for a DYT1 mutation. Patients' characteristics are summarized in table 1 . The last follow-up was performed in August 2006.
Neurosurgical Technique/Implants
Bilateral pallidal electrode implantation (model 3387; Medtronic, Minneapolis, Minn., USA) with intraoperative macroelectrode testing was either performed under propofol (12 patients) or local (6 patients) anesthesia with MRI-guided stereotaxy using a modified Leksell/Lerch system (Munich) or ventriculography combined with 3D stereotactic CT and MR imaging and a modified Riechert-Mundinger stereotactic head ring (Cologne).
The methodology applied for imaging, treatment planning and implantation has been published in detail elsewhere [11, 20] . The preliminary target within the GPi was defined as follows: 3 mm anterior to the AC-PC midpoint, 18-22 mm lateral to the midline and 3-6 mm below the IC plane [21] . The standard target coordinates were adjusted based on individual anatomical landmarks (third ventricle/optical tract). Intraoperative microelectrode recordings were not performed in this study. Permanent implantation of the stimulation system into a subcutaneous infraclavicular pouch (IPG, model, Soletra or Kinetra; Medtronic) was performed either after 3-5 days of testing for side effects with an external pulse generator system using percutaneous extensions (12 patients, Munich) or immediately after implantation of the 
Stimulation/Parameters
The most distal electrode contact of the quadripolar electrode which caused no side effects when activated was chosen for continuous monopolar stimulation with comparably high intensity from the beginning (mean 80 A). Thereafter, the amplitude was stepwise increased over several days to determine for each patient individually a level which gained maximum clinical response with no or minimal side effects (e.g. phosphenes, motor symptoms and speech disturbance). Stimulation parameters are summarized in table 2 .
Patient Evaluation
Clinical outcome was assessed preoperatively, at discharge from hospital (mean 10 days after initial programming), and 3, 6 and 12 months postoperatively and then annually) using the Burke-Fahn-Marsden (BFM) dystonia rating scale (motor and disability) for patients with generalized dystonia and the Tsui rating scale for patients with focal or segmental dystonia [22, 23] . The Tsui score consists of several subscores assessing the amplitude and duration of sustained movements, shoulder elevation and tremor. Due to its detailed subscores, we considered this score to be best suited to evaluate torticollis and segmental dystonia.
Twelve patients received an immediate postoperative MRI to control electrode position. In 6 patients, the coordinates of the final electrode position were taken from intraoperative stereotactic plain X-ray images. Finally, placement of the electrode (active contact) inside the GPi was verified using the individual customized planning software for co-registration with the treatment planning MRI (and the Schaltenbrand brain atlas [24] ). The exact position of all active contacts was referenced to the AC-PC midpoint (Matlab 7.1; MathWorks, Natick, Mass., USA).
Statistical Methods
The Wilcoxon matched-pair signed-rank test was applied to compare changes in the rating scale scores pre-and postoperatively [response at discharge, 3 and 12 months, and long-term follow-up ( 1 36 months)]. Student's t test was used to analyze differences between population subgroups. A correlation analysis using the Spearman correlation coefficient along with linear regression analysis was used to test for pretreatment prognosticators of longterm outcome (at 36 months) as well as correlation between electrode localization and outcome. p ! 0.05 was considered statistically significant. Statistical analyses were performed using the SPSS 14.0 and 16.0 software (SPSS, Chicago, Ill., USA).
Results
Clinical Patient Outcome
In summary, most of our patients demonstrated a very rapid response to DBS with significant improvement in their symptoms already during the 1st postoperative week. Improvement was 1 50% in 4/9 patients with generalized and in 5/9 patients with focal/segmental dystonia. The follow-up of the entire patient group ranged from 37 to 90 months (mean 60 months).
Generalized Dystonia. Patients with generalized dystonia were severely affected with a high mean preoperative BFM movement and disability score of 57 (median 55, range 27-106) and 14.4 (median 14, range 7-26), respectively. At discharge from hospital, there were mean improvements in the BFM movement score of 39.4% (median 38, range 0-68.8%) and in the BFM disability score of 29.9% (median 29, range 7.1-71.4%). After 3 months, both scores (movement and disability) further improved in 2 patients. In comparison to the immediate postoperative status, the values remained stable in 5 individuals and had worsened in 2 patients. Intermediate analysis at 12 months revealed mean improvements in the BMF movement and disability scores of 42.5 (median 63, range -16.0 to 81.3%) and 37.9% (median 30, range 7.1-73.3%). These improvements remained constant at the longterm-follow up at 36 months and at the last follow-up in 5, severely reduced in 2 and moderately reduced in 2 patients ( fig. 1 , 2 ). The mean percent improvements in comparison to the preoperative status together with the statistical values are listed in table 3 . Individual scores at follow-up are listed in table 4 . Statistical Analysis. At the 3-and 12-month, and at the long-term follow-ups (36 months and 1 36 months, with a mean of 60 months), mean improvements were significantly different compared with the preoperative status (Wilcoxon's matched-pair signed-rank test) for both groups, i.e. general dystonia (motor and disability score, table 3 ) and focal/segmental dystonia ( table 5 ) . There was no statistically significant difference in the long-term benefit between the 36-month and the last ('open-label' longterm) follow-up. In generalized dystonia, correlation and linear regression analysis showed age at surgery (r 2 = 0.593, significance 0.004) and duration of disease prior to DBS (r 2 = 0.712, significance 0.004) to be significant predictors Graph showing the course of BFM movement ( 1 ) and BFM disability scores ( 2 ) for the 9 patients with generalized dystonia in the long-term follow-up. The reference point was the date of electrode implantation. Individual outcome scores applying either the BFM score in generalized dystonia or the Tsui-score in focal/segmental dystonia. The 36-month follow-up was performed within a range of 32-40 months. ID = Patient identification number; PO = preoperatively; FU = follow-up; BFM-M = BFM movement; BFM-D = BFM disability. The 3 patients with the most anteriorly positioned electrodes had no (patients 4 and 6) or only moderate (patient 5) long-term success. There was neither a statistically significant correlation between electrode position and outcome in patients with extremely worse or better outcome nor in the subgroups with an outcome ! or 1 50% ( fig. 4 ) .
Stimulation Parameters
Parameters at discharge and at follow-up are given in table 2 . The initial amplitude settings (on discharge) had to be increased in all patients during follow-up in order to further optimize the control of involuntary movements.
Pulse Generator Replacement. The mean interval for replacement was 43.4 (17 patients, range 31-59 months) and 38.3 months (5 patients, range 32-48 months) for the first and second replacement, respectively. There was no statistically significant difference in time to replacement between the different types of IPG (Itrel II, Soletra or Kinetra).
Complications
Perioperative Mortality and Morbidity. Despite 1 case with a subcutaneous hematoma at the site of the extension cable (complete recovery without permanent deficits), there was no other directly surgery-related morbidity or mortality in this patient series.
Infections. Local infections were encountered in 2 patients: One patient (patient 7) presented with local infection at the burr hole necessitating removal of the left DBS electrode 14 days after the primary procedure. Re-implantation was performed 3 months later without complications, and the same excellent stimulation result as before was achieved. Another patient (patient 13) suffered from a local infection at the right infraclavicular IPG 6 weeks after IPG replacement in an outside institution (46 months after primary implantation) requiring IPG explantation. Re-implantation was performed 6 weeks later without further sequelae.
Long-Term Complications/Side Effects. One young female patient suffering from generalized dystonia (patient 9) with an excellent clinical course and initially significant improvement due to GPi-DBS developed (with a delay of 3 years) extreme psychosocial behavioral abnormalities (aggressiveness/uncooperativeness) necessitating intensive psychological treatment. With adequate psychological support, her clinical status stabilized. Depending on stimulation intensity, mild speech disturbances occurred in 2 patients. Due to the otherwise excellent clinical response, this mild impairment was well accepted. An accidental inactivation of the IPGs (i.e. an airport metal detector and a professional kitchen machine) with almost immediate re-occurrence of dystonic symptoms was observed in 2 patients.
Hardware Complications. In 1 patient (patient 9), we documented loosening of the burr hole cap with consecutive electrode dislocation (39 months postoperatively) and in the later course (58 months postoperatively) breakage of the extension cable. Both events were accompanied by a loss of stimulation and consecutive severe worsening of clinical symptoms. Complete restitution could be achieved in either event by immediate operative revision (i.e. revision of the DBS electrode and the extension cable, respectively). 
Discussion
High-frequency DBS with neuromodulatory instead of destructive effects, hence being reversibly and individually adjustable, and with its high therapeutic efficacy has replaced ablative procedures like pallidotomy or thalamotomy during the last 10 years. This development was paralleled by an increasing acceptance of stereotactic neurosurgery for the treatment of movement disorders. [8] [9] [10] [11] [12] [13] [14] [15] 25] . Moreover, prospective multicenter trials with a controlled (randomized) protocol proved the efficacy of DBS for patients with generalized dystonia [16] [17] [18] .
The present analysis addressing postoperative and long-term (mean follow-up: 60 months) clinical results in a cohort of 18 patients covered different types of primary dystonia, including the largest long-term series of patients suffering from focal/segmental dystonia to date. Clinical symptoms improved in both patient groups significantly. In detail, at the 36-month and at the last fol- low-up examination (36-90 months), the average clinical benefit expressed as a reduction in the BMF movement and disability scores were 50/33 and 47/27%, respectively, in the group with generalized dystonia and 62 and 60% in patients with focal/segmental dystonia who were assessed using the Tsui scale. In contrast to most previous reports, in the present study, we documented for a reasonably high number of patients (9/18) a significant improvement in symptoms (improvement 1 50%) already during the 1st postoperative week [10, [14] [15] [16] . In agreement with Kupsch et al. [18] , these early beneficial effects became visible in mobile dystonia rather than in fixed dystonic postures. However, this is observation cannot be generalized since there was no statistically sound proof. For reasons of clinical practicability, we applied two different score systems complicating the direct comparison of patients with general dystonia and those with predominant torticollis in the segmental/focal group. In the latter cohort, the Tsui score, a scoring system for torticollis widely used by European groups, had been applied, since features of focal/segmental dystonia are assessed in more detail [23] . As a consequence, particular aspects of the results will be discussed individually for both patient cohorts.
Generalized Dystonia
The present analysis showed that the significant improvements in BFM scores 12 months after the start of DBS (movement: 46.8 8 36.5% and disability: 26.7 8 37.7%) were maintained during the long-term follow-up (maximum follow-up time: 72 months, mean follow-up time: 59.6 months) in 5/9 patients, with a mean motor improvement of 50.3% at the 36-month follow-up and excellent results in 3 young patients (age at surgery 12, 13 and 20 years), with an improvement of 81, 82 and 82%, respectively. These results compare very well to the prospective short-and long-term outcome reported by Vidailhet et al. [16, 17] who also found improvements 1 75% in (only) one third of their patients. However, in 3 patients with significant initial benefit, we registered moderate (patients 4-6) and in 1 patient (patient 3) substantial worsening in the positive stimulation effect over time ( fig. 1 , 2 ; table 3 , 4 ) . In this group of patients with a history of dystonia prior to treatment of 1 15 years, longterm outcome was found to be statistically significantly worse than in individuals with a shorter history of dystonia (mean improvement in the BFM movement score 25.4 vs. 73.6%, p = 0.03). Moreover, in contrast to other studies, correlation and linear regression analysis revealed age at surgery and duration of disease prior DBS to be statistically significant predictors for long-term outcome (at 36 months) in our series [18] . In concordance to the results of the randomized controlled series by Kupsch et al. [18] , there was also no statistical difference in outcome between the patients with or without DYTI mutation in our patient cohort.
These observations might indicate the necessity of early neurosurgical intervention to achieve an optimal clinical outcome. Although the results have to be confirmed in a prospective study, early treatment seems to be even more important in pediatric/juvenile patients to prevent irreversible impairment of motor function (muscle, joint and bone destruction/deformity).
Further studies in patients with insufficient or decreasing response have to elucidate the benefit of low-frequency stimulation (60 Hz), yielding significant improvement in 89% after 12 months in a study by Alterman et al. [26] , or targeting of the nucleus subthalmicus, an alternative approach with very promising results [27, 28] . However, both concepts seem very interesting (with obvious advantages: e.g. a longer battery life) and might be applied in our institution in the future, especially in patients with inappropriate response to 'standard' high-frequency Gpi-DBS.
Electrode Position
Despite the fact that the 3 patients with the most anteriorly positioned electrodes had no (patients 4 and 6) or only moderate (patient 5) long-term improvement (generalized dystonia), there was neither a statistically significant correlation in electrode position and outcome in patients with extremely worse or better outcome nor in the subgroups with an outcome ! or 1 50% ( fig. 4 ) . In general, position of the active contacts within the GPi was in agreement with previously published results [13] .
Segmental/Focal Dystonia
In accordance with other studies, outcome in patients with segmental/focal dystonia varied largely during longterm follow-up, which is reflected by the great standard deviation in documented scores (6.3 at the last follow-up) [8, 14] . There was neither a significantly higher degree of fixed posture in the patients with a less favorable response (as documented by the Tsui subscores, data not shown) nor could statistically significant predictors for outcome be detected. The best effect was observed for cervical dystonic symptoms (2 patients with pure torticollis showed a stable complete relief of their symptoms) as well as for the Meige syndrome. In our series, results were comparably worse in patients with dystonic movements in the shoulder/arm region and/or in patients with predominating clonic-dystonic symptoms (e.g. dystonic tremor). However, bearing in mind that other groups applied voltages as high as 5.0 V, generally stating that GPi-DBS is less effective in 'complex' segmental dystonia may be misleading, since the voltages used in our patients ( ! 3.6 V) may have been too low to observe a significant benefit [19, 29] . Despite these limitations, the overall improvement remained stable if referred to the total follow-up time (maximum 81 months) and was statistically significant compared with baseline values.
These results support the important role of GPi-DBS in patients with cervical dystonia, confirming previous data in patients with a significantly shorter follow-up [18, [29] [30] [31] .
Complications
In contrast to other reports covering a number of patients comparable to our series, stereotactic implantation of the brain electrodes did not give rise to mortality or severe morbidity (e.g. symptomatic intracerebral hemorrhage or new neurological sequelae) [32] . Also, the rate of other perioperative adverse events was low (1/18 patients, 6%) in our patients. The comparably high number of patients (4/18 patients, 22.2%) who presented with implantrelated (long-term) complications (local infections, electrode dislocation or peripheral cable breakage) is in accordance with previously published reports addressing this particular problem [18, 33] . Of note, the two infections encountered were not long-term complications. In the patient requiring electrode explantation, the local infection at the burr hole occurred 14 days after implantation and after 10 days of externalization of the electrodes. In the patient with IPG infection, infection manifested at the long-term follow-up (46 months after initial surgery); however, the patient had undergone IPG replacement only 6 weeks prior to manifestation of the infection.
With the exception of temporary aggressive behavior documented in a young female suffering from generalized dystonia, who responded very well to adequate psychological treatment, other mood disturbances were not observed (e.g. a tendency to depressive or even suicidal behavior), being in contrast to others [34] .
The mild speech disturbances (dysarthria) noted in 2 cases were not clinically significant and were well tolerated, because of the excellent clinical improvement in their dystonic symptoms.
Conclusion
GPi-DBS is safe in patients suffering from primary generalized, segmental or focal dystonia with excellent short-term stimulation effects as already published. In the present analysis, long-term results were also excellent in 3 young patients with generalized dystonia and 2 patients with torticollis. Patients with segmental dystonia showed marked but incomplete relief of their symptoms. Early treatment seems to be crucial to achieve optimal therapeutic benefit in patients with generalized dystonia.
